APO RESEARCH · REPORT
Oncology Based Preclinical CRO
Preclinical research refers to before testing a drug in people, researchers must find out whether it has the potential to cause serious harm, also called toxicity. A Preclinical CRO, or preclinical contract research organization, provides the experience, knowledge, and skill required to take a pharmaceutical product or medical device from the drawing board to distribution. This journey entails a plethora of activities that involve scientists, medical personnel, administrators, governmental and industry liaisons, marketing experts, and a host of other technical and creative individuals. Rarely is this unique combination of credentials and craft already present within a sponsoring organization. The CRO industry emerged to fill this much-needed role, to provide the expertise required to bring a pharmaceutical product or medical device into the marketplace as quickly and smoothly as possible.
Product & engineering
Understand the product.
Preclinical research refers to before testing a drug in people, researchers must find out whether it has the potential to cause serious harm, also called toxicity. A Preclinical CRO, or preclinical contract research organization, provides the experience, knowledge, and skill required to take a pharmaceutical product or medical device from the drawing board to distribution. This journey entails a plethora of activities that involve scientists, medical personnel, administrators, governmental and industry liaisons, marketing experts, and a host of other technical and creative individuals. Rarely is this unique combination of credentials and craft already present within a sponsoring organization. The CRO industry emerged to fill this much-needed role, to provide the expertise required to bring a pharmaceutical product or medical device into the marketplace as quickly and smoothly as possible.
Selected research
Industry Research
Oncology Based Preclinical CRO Industry Research Report 2026
Market perspective
Preclinical research refers to before testing a drug in people, researchers must find out whether it has the potential to cause serious harm, also called toxicity. A Preclinical CRO, or preclinical contract research organization, provides the experience, knowledge, and skill required to take a pharmaceutical product or medical device from the drawing board to distribution. This journey entails a plethora of activities that involve scientists, medical personnel, administrators, governmental and industry liaisons, marketing experts, and a host of other technical and creative individuals. Rarely is this unique combination of credentials and craft already present within a sponsoring organization. The CRO industry emerged to fill this much-needed role, to provide the expertise required to bring a pharmaceutical product or medical device into the marketplace as quickly and smoothly as possible.
The industry's leading producers are Crown Bioscience, Charles River and ICON, with revenues of 18.32 percent, 13.86 percent and 9.13 percent in 2019.
Report Scope
Read the full market overview
This report quantifies the global Oncology Based Preclinical CRO market in terms of revenue (US$ million) and, where applicable, service volume (), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Oncology Based Preclinical CRO.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Oncology Based Preclinical CRO Market by Company
Crown Bioscience
Charles River
ICON
Eurofins Scientific
Taconic Biosciences
Covance
EVOTEC
The Jackson Laboratory
MI Bioresearch
Champion Oncology
Wuxi AppTec.
Xentech
Living Tumor Laboratory
Oncology Based Preclinical CRO Segment by Type
Blood Cancer
Solid Tumors
Others
Oncology Based Preclinical CRO Segment by Application
In Vitro
In Vivo
Oncology Based Preclinical CRO Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Oncology Based Preclinical CRO market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Oncology Based Preclinical CRO and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Oncology Based Preclinical CRO.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Oncology Based Preclinical CRO companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Blood Cancer
- Solid Tumors
- Others
Applications
- In Vitro
- In Vivo
Companies covered
- Crown Bioscience
- Charles River
- ICON
- Eurofins Scientific
- Taconic Biosciences
- Covance
- EVOTEC
- The Jackson Laboratory
- MI Bioresearch
- Champion Oncology
- Wuxi AppTec.
- Xentech
- Living Tumor Laboratory
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Oncology Based Preclinical CRO by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Blood Cancer
- 2.2.3 Solid Tumors
- 2.2.4 Others
- 2.3 Oncology Based Preclinical CRO by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 In Vitro
- 2.3.3 In Vivo
- 2.4 Assumptions and Limitations
3 Oncology Based Preclinical CRO Breakdown Data by Type
- 3.1 Global Oncology Based Preclinical CRO Historic Market Size by Type (2021-2026)
- 3.2 Global Oncology Based Preclinical CRO Forecasted Market Size by Type (2027-2032)
4 Oncology Based Preclinical CRO Breakdown Data by Application
- 4.1 Global Oncology Based Preclinical CRO Historic Market Size by Application (2021-2026)
- 4.2 Global Oncology Based Preclinical CRO Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Oncology Based Preclinical CRO Market Perspective (2021-2032)
- 5.2 Global Oncology Based Preclinical CRO Growth Trends by Region
- 5.2.1 Global Oncology Based Preclinical CRO Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Oncology Based Preclinical CRO Historic Market Size by Region (2021-2026)
- 5.2.3 Oncology Based Preclinical CRO Forecasted Market Size by Region (2027-2032)
- 5.3 Oncology Based Preclinical CRO Market Dynamics
- 5.3.1 Oncology Based Preclinical CRO Industry Trends
- 5.3.2 Oncology Based Preclinical CRO Market Drivers
- 5.3.3 Oncology Based Preclinical CRO Market Challenges
- 5.3.4 Oncology Based Preclinical CRO Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Oncology Based Preclinical CRO Players by Revenue
- 6.1.1 Global Top Oncology Based Preclinical CRO Players by Revenue (2021-2026)
- 6.1.2 Global Oncology Based Preclinical CRO Revenue Market Share by Players (2021-2026)
- 6.2 Global Oncology Based Preclinical CRO Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Oncology Based Preclinical CRO Head Office and Area Served
- 6.4 Global Oncology Based Preclinical CRO Players, Product Type & Application
- 6.5 Global Oncology Based Preclinical CRO Manufacturers Established Date
- 6.6 Global Oncology Based Preclinical CRO Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Oncology Based Preclinical CRO Market Size (2021-2032)
- 7.2 North America Oncology Based Preclinical CRO Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Oncology Based Preclinical CRO Market Size by Country (2021-2026)
- 7.4 North America Oncology Based Preclinical CRO Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Oncology Based Preclinical CRO Market Size (2021-2032)
- 8.2 Europe Oncology Based Preclinical CRO Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Oncology Based Preclinical CRO Market Size by Country (2021-2026)
- 8.4 Europe Oncology Based Preclinical CRO Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Oncology Based Preclinical CRO Market Size (2021-2032)
- 9.2 Asia-Pacific Oncology Based Preclinical CRO Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Oncology Based Preclinical CRO Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Oncology Based Preclinical CRO Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Oncology Based Preclinical CRO Market Size (2021-2032)
- 10.2 South America Oncology Based Preclinical CRO Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Oncology Based Preclinical CRO Market Size by Country (2021-2026)
- 10.4 South America Oncology Based Preclinical CRO Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Oncology Based Preclinical CRO Market Size (2021-2032)
- 11.2 Middle East & Africa Oncology Based Preclinical CRO Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Oncology Based Preclinical CRO Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Oncology Based Preclinical CRO Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Crown Bioscience
- 12.1.1 Crown Bioscience Company Information
- 12.1.2 Crown Bioscience Business Overview
- 12.1.3 Crown Bioscience Revenue in Oncology Based Preclinical CRO Business (2021-2026)
- 12.1.4 Crown Bioscience Oncology Based Preclinical CRO Product Portfolio
- 12.1.5 Crown Bioscience Recent Developments
- 12.2 Charles River
- 12.2.1 Charles River Company Information
- 12.2.2 Charles River Business Overview
- 12.2.3 Charles River Revenue in Oncology Based Preclinical CRO Business (2021-2026)
- 12.2.4 Charles River Oncology Based Preclinical CRO Product Portfolio
- 12.2.5 Charles River Recent Developments
- 12.3 ICON
- 12.3.1 ICON Company Information
- 12.3.2 ICON Business Overview
- 12.3.3 ICON Revenue in Oncology Based Preclinical CRO Business (2021-2026)
- 12.3.4 ICON Oncology Based Preclinical CRO Product Portfolio
- 12.3.5 ICON Recent Developments
- 12.4 Eurofins Scientific
- 12.4.1 Eurofins Scientific Company Information
- 12.4.2 Eurofins Scientific Business Overview
- 12.4.3 Eurofins Scientific Revenue in Oncology Based Preclinical CRO Business (2021-2026)
- 12.4.4 Eurofins Scientific Oncology Based Preclinical CRO Product Portfolio
- 12.4.5 Eurofins Scientific Recent Developments
- 12.5 Taconic Biosciences
- 12.5.1 Taconic Biosciences Company Information
- 12.5.2 Taconic Biosciences Business Overview
- 12.5.3 Taconic Biosciences Revenue in Oncology Based Preclinical CRO Business (2021-2026)
- 12.5.4 Taconic Biosciences Oncology Based Preclinical CRO Product Portfolio
- 12.5.5 Taconic Biosciences Recent Developments
- 12.6 Covance
- 12.6.1 Covance Company Information
- 12.6.2 Covance Business Overview
- 12.6.3 Covance Revenue in Oncology Based Preclinical CRO Business (2021-2026)
- 12.6.4 Covance Oncology Based Preclinical CRO Product Portfolio
- 12.6.5 Covance Recent Developments
- 12.7 EVOTEC
- 12.7.1 EVOTEC Company Information
- 12.7.2 EVOTEC Business Overview
- 12.7.3 EVOTEC Revenue in Oncology Based Preclinical CRO Business (2021-2026)
- 12.7.4 EVOTEC Oncology Based Preclinical CRO Product Portfolio
- 12.7.5 EVOTEC Recent Developments
- 12.8 The Jackson Laboratory
- 12.8.1 The Jackson Laboratory Company Information
- 12.8.2 The Jackson Laboratory Business Overview
- 12.8.3 The Jackson Laboratory Revenue in Oncology Based Preclinical CRO Business (2021-2026)
- 12.8.4 The Jackson Laboratory Oncology Based Preclinical CRO Product Portfolio
- 12.8.5 The Jackson Laboratory Recent Developments
- 12.9 MI Bioresearch
- 12.9.1 MI Bioresearch Company Information
- 12.9.2 MI Bioresearch Business Overview
- 12.9.3 MI Bioresearch Revenue in Oncology Based Preclinical CRO Business (2021-2026)
- 12.9.4 MI Bioresearch Oncology Based Preclinical CRO Product Portfolio
- 12.9.5 MI Bioresearch Recent Developments
- 12.10 Champion Oncology
- 12.10.1 Champion Oncology Company Information
- 12.10.2 Champion Oncology Business Overview
- 12.10.3 Champion Oncology Revenue in Oncology Based Preclinical CRO Business (2021-2026)
- 12.10.4 Champion Oncology Oncology Based Preclinical CRO Product Portfolio
- 12.10.5 Champion Oncology Recent Developments
- 12.11 Wuxi AppTec.
- 12.11.1 Wuxi AppTec. Company Information
- 12.11.2 Wuxi AppTec. Business Overview
- 12.11.3 Wuxi AppTec. Revenue in Oncology Based Preclinical CRO Business (2021-2026)
- 12.11.4 Wuxi AppTec. Oncology Based Preclinical CRO Product Portfolio
- 12.11.5 Wuxi AppTec. Recent Developments
- 12.12 Xentech
- 12.12.1 Xentech Company Information
- 12.12.2 Xentech Business Overview
- 12.12.3 Xentech Revenue in Oncology Based Preclinical CRO Business (2021-2026)
- 12.12.4 Xentech Oncology Based Preclinical CRO Product Portfolio
- 12.12.5 Xentech Recent Developments
- 12.13 Living Tumor Laboratory
- 12.13.1 Living Tumor Laboratory Company Information
- 12.13.2 Living Tumor Laboratory Business Overview
- 12.13.3 Living Tumor Laboratory Revenue in Oncology Based Preclinical CRO Business (2021-2026)
- 12.13.4 Living Tumor Laboratory Oncology Based Preclinical CRO Product Portfolio
- 12.13.5 Living Tumor Laboratory Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst